Dear Patty...

Patty is merely a pawn. She is sitting idle in a position with no power or a plan. Typical big pharma attitude. The situation is over her head and above her pay grade. Time to look for another leader, or a real leader for that matter.
Way to look pretty Patty. Pretty pathetic.
 












By this time next year OPKO renal will not exist. The powers that be will make a nice pile of cash while the rest of us will get nothing.
I agree with your assessment. Frosty is getting up there and will retire with billions. He will sell off Rayaldee which will bring more value to shareholders leaving BioReference Labs as the business focus.
I think it will happen this year. Time has come.
 


















That is the way it goes. We were sold a bill of goods. Our stock options are not worth anything substantial. chump change

Price target believe it or not is $8. I don’t see how; however someone must know something we don’t. Or it could be a little wishful thinking. All will be predicated on release of earnings for Q4 (which should be good) coming soon to a theater near you. You could also factor in the human growth hormone affiliation with Pfizer.
 






Price target believe it or not is $8. I don’t see how; however someone must know something we don’t. Or it could be a little wishful thinking. All will be predicated on release of earnings for Q4 (which should be good) coming soon to a theater near you. You could also factor in the human growth hormone affiliation with Pfizer.
It certainly isn’t Rayaldee now that foundation money can’t be used.
 






Price target believe it or not is $8. I don’t see how; however someone must know something we don’t. Or it could be a little wishful thinking. All will be predicated on release of earnings for Q4 (which should be good) coming soon to a theater near you. You could also factor in the human growth hormone affiliation with Pfizer.

Need to factor in a whole lot of GROWTH hormone. Especially for the little people in this renal division.
 






























Patty is merely a pawn. She is sitting idle in a position with no power or a plan. Typical big pharma attitude. The situation is over her head and above her pay grade. Time to look for another leader, or a real leader for that matter.
Way to look pretty Patty. Pretty pathetic.
So typical to attack any successful woman in a position of power. I’m sure that if a man was in charge Rayaldee sales would instantly skyrocket. Give me a break.
 






So typical to attack any successful woman in a position of power. I’m sure that if a man was in charge Rayaldee sales would instantly skyrocket. Give me a break.

Facts or attacks?!! First you need to define successful. The current NSD has not brought one successful strategy to the table. Regardless of gender. Do you believe that the current NSD is even capable of leading this team of elite sales professionals? No more breaks or excuses. Get to work.
 






So typical to attack any successful woman in a position of power. I’m sure that if a man was in charge Rayaldee sales would instantly skyrocket. Give me a break.
Competency has no boundaries in terms of race color creed gender religion etc. The fact is the current leader is incompetent and happens to be a female... no one disputes that.